The Tax Reasons, and Problems, Behind Pfizer’s Bid for a Rival
Pfizer Inc. is trying to acquire AstraZeneca for both tax and strategic reasons. First, the tax reasons: Internal Revenue Service regulations have made it difficult for companies to leave the U.S. to go to [...]

